1 unchanged sentence
Trading Arrangements
−Removed: During the quarter ended March 31, 2026, none of our directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement (as such terms are defined pursuant to Item 408(a) of Regulation S-K).
+Added: During the quarter ended June 30, 2026, none of our directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement (as such terms are defined pursuant to Item 408(a) of Regulation S-K).
Exhibit Incorporated by Reference Filed
5 unchanged sentences
8-K 001-42001 3.2 04/09/2024
−Removed: 10.1 2026 Employment Inducement Equity Incentive Plan and forms of agreements thereunder .
−Removed: 10.16 03/05/2026
31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
11 unchanged sentences
Contineum Therapeutics, Inc.
+Added: July 30, 2026
/s/ Carmine Stengone
2 unchanged sentences
(Principal Executive Officer)
+Added: July 30, 2026
/s/ Peter Slover
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.